Rolls-Royce Holdings plc - RR.L

RR.L Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
RR.L	1.4	5.2	6.3	8.9	33.0	102.7	441.2	173.2	97.6	387.4
S&P 500	0.5	2.1	2.4	5.5	10.1	25.8	38.7	84.0	198.2	34547.3

Compare RR.L with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	RR.L
name	Rolls-Royce Holdings plc
price	611.6
changes percentage	1.359
change	8.2
day low	598
day high	611.6
year high	611.6
year low	297
market cap	52015968987
price avg 50	569.98
price avg 200	501.5755
exchange	LSE
volume	70630972
avg volume	28410159
open	605
previous close	603.4
eps	0.28
pe	21.84
earnings announcement	2025-02-27T08:30:00.000+0000
shares outstanding	8504900096
timestamp	2025-01-23 17:38:45

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 72.3%

Overall Quarterly Financial Health: 50.0%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
revenue	16486000000	13520000000	21.94
gross profit	3620000000	2757000000	31.30
gross profit ratio	0.22	0.2	7.68
research and development expenses	739000000	797000000	-7.28
operating expenses	1676000000	1968000000	-14.84
interest income	164000000	35000000	368.57
interest expense	369000000	343000000	7.58
ebitda	3744000000	1291000000	190.01
ebitdaratio	0.23	0.1	137.83
operating income	1944000000	339000000	473.45
operating income ratio	0.12	0.03	370.28
net income	2412000000	-1194000000	302.01
net income ratio	0.15	-0.09	265.67
eps	0.29	-0.14	307.14

Overall Score of Annual Income Statement

0.75 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 16,486 million in 2023 from 13,520 million in 2022 representing a change of 21.94%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 3,620 million in 2023 from 2,757 million in 2022 representing a change of 31.3%. This indicates a sales profitability growth, which is a positive sign for the company.

  Operating Expenses: Operating Expenses decreased to 1,676 million in 2023 from 1,968 million in 2022 representing a change of -14.84%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 3,744 million in 2023 from 1,291 million in 2022 representing a change of 190.01%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Net Income: Net income increased to 2,412 million in 2023 from -1,194 million in 2022 representing a change of 302.01%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 0.29 in 2023 from 0.29 in 2022 representing a change of 307.14%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Research and Development (R&D) Expenses: R&D Expenses decreased to 739 million in 2023 from 797 million in 2022 representing a change of -7.28%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  Operating Income: Operating income decreased to 1,944 million in 2023 from 339 million in 2022 representing a change of 473.45%. The decrease in operating income indicates worse operational performance and decreased profitability.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0000000000
revenue	4430500000	4430500000	0.0
gross profit	1054000000	1054000000	0.0
gross profit ratio	0.24	0.24	0.0
research and development expenses	157500000	157500000	0.0
operating expenses	333000000	333000000	0.0
interest income	13000000	13000000	0.0
interest expense	0	0	NaN
ebitda	628500000	628500000	0.0
ebitdaratio	0.14	0.14	0.0
operating income	590500000	590500000	0.0
operating income ratio	0.13	0.13	0.0
net income	574500000	574500000	0.0
net income ratio	0.13	0.13	0.0
eps	0.07	0.07	0.0

Overall Score of Quarterly Income Statement

0.5 out of 1

Detailed Analysis

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
total assets	31512000000	29450000000	7.00
total liabilities	35141000000	35466000000	-0.92
total equity	-3629000000	-6016000000	39.68
cash and cash equivalents	3505000000	2372000000	47.77
short term investments	10000000	23000000	-56.52
long term investments	764000000	458000000	66.81
total current assets	18220000000	16011000000	13.80
total non current assets	13292000000	13439000000	-1.09
total current liabilities	14981000000	13918000000	7.64
total non current liabilities	20160000000	21548000000	-6.44
common stock	1684000000	1674000000	0.60
retained earnings	-7212000000	-9789000000	26.33
total debt	5759000000	5955000000	-3.29

Overall Score of Annual Balance Sheet

0.8 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 31,512 million in 2023 from 29,450 million in 2022 representing a change of 7.0%. Suggesting a growth in asset holdings.

  Total Liabilities: Total Liabilities decreased to 35,141 million in 2023 from 35,466 million in 2022 representing a change of -0.92%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to -3,629 million in 2023 from -6,016 million in 2022 representing a change of 39.68%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 3,505 million in 2023 from 2,372 million in 2022 representing a change of 47.77%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 18,220 million in 2023 from 16,011 million in 2022 representing a change of 13.8%. This indicates a better liquidity position.

  Common Stock: Common Stock increased to 1,684 in 2023 from 1,674 in 2022 representing a change of 0.6%. This indicates an increase in ownership interest.

  Retained Earnings: Retained Earnings increased to -7,212 million in 2023 from -9,789 million in 2022 representing a change of 26.33%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 5,759 million in 2023 from 5,955 million in 2022 representing a change of -3.29%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Short Term Investments: Short Term Investments decreased to 10 million in 2023 from 23 million in 2022 representing a change of -56.52%. This indicates a decrease in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities increased to 14,981 million in 2023 from 13,918 million in 2022 representing a change of 7.64%. This indicates a higher short-term debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0000000000
total assets	33011000000	33011000000	0.0
total liabilities	35248000000	35248000000	0.0
total equity	-2237000000	-2237000000	0.0
cash and cash equivalents	4319000000	4319000000	0.0
short term investments	17000000	17000000	0.0
long term investments	804000000	804000000	0.0
total current assets	19485000000	19485000000	0.0
total non current assets	13526000000	13526000000	0.0
total current liabilities	15264000000	15264000000	0.0
total non current liabilities	19984000000	19984000000	0.0
common stock	1701000000	1701000000	0.0
retained earnings	-5818000000	-5818000000	0.0
total debt	4988000000	4988000000	0.0

Overall Score of Quarterly Balance Sheet

0.5 out of 1

Detailed Analysis

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
net change in cash	1126000000	-34000000	3411.76
operating cash flow	2485000000	1850000000	34.32
free cash flow	1772000000	1491000000	18.85
capital expenditure	-713000000	-359000000	-98.61
depreciation and amortization	948000000	768000000	23.44
deferred income tax	0	-857000000	100.00
stock based compensation	66000000	47000000	40.43
accounts payables	-1357000000	857000000	-258.34
inventory	-200000000	-887000000	77.45
acquisitions net	-27000000	1374000000	-101.97
investments in property plant and equipment	-429000000	-359000000	-19.50
net cash used for investing activites	-726000000	826000000	-187.89
debt repayment	1000000	-2023000000	100.05
common stock issued	0	0	NaN
common stock repurchased	-1000000	-1000000	0.00
dividends paid	-1000000	-1000000	0.00
net cash used provided by financing activities	-549000000	-2866000000	80.84
cash at end of period	3731000000	2605000000	43.22
accounts receivables	1357000000	1697000000	-20.04
cash at beginning of period	2605000000	2639000000	-1.29

Overall Score of Annual Cashflow Statement

0.62 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 1,126 million in 2023 from -34 million in 2022 representing a change of 3411.76%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 2,485 million in 2023 from 1,850 million in 2022 representing a change of 34.32%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 1,772 million in 2023 from 1,491 million in 2022 representing a change of 18.85%. This indicates an increase in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure decreased to -713 million in 2023 from -359 million in 2022 representing a change of -98.61%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Accounts Receivables: Accounts Receivables decreased to 1,357 million in 2023 from 1,697 million in 2022 representing a change of -20.04%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

• 📉 Negative Indicators

  Deferred Income Tax: Deferred Income Tax increased to 0 million in 2023 from -857 million in 2022 representing a change of 100.0%. This indicates that the company's tax liability for future periods has increased.

  Stock-Based Compensation: Stock-Based Compensation increased to 66 million in 2023 from 47 million in 2022 representing a change of 40.43%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Accounts Payables: The absolute value of Accounts Payables increased to 1,357 million in 2023 from 857 million in 2022 representing a change of -258.34%. This indicates that the company has increased its outstanding obligations to its suppliers.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0000000000
operating cash flow	834500000	834500000	0.0
free cash flow	768000000	768000000	0.0
capital expenditure	-66500000	-66500000	0.0
depreciation and amortization	101500000	101500000	0.0
deferred income tax	0	0	NaN
stock based compensation	29500000	29500000	0.0
accounts receivables	535000000	535000000	0.0
accounts payables	0	0	NaN
inventory	-320500000	-320500000	0.0
acquisitions net	0	0	NaN
investments in property plant and equipment	-66500000	-66500000	0.0
net cash used for investing activites	-159500000	-159500000	0.0
debt repayment	0	0	NaN
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	0	0	NaN
net cash used provided by financing activities	-364000000	-364000000	0.0
net change in cash	291000000	291000000	0.0
cash at end of period	291000000	291000000	0.0
cash at beginning of period	0	0	NaN

Overall Score of Quarterly Cashflow Statement

0.5 out of 1

Detailed Analysis

Earnings Transcripts ⓘ

We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.

Note: The years mentioned below are fiscal years in accounting.

Q2 2024 Earnings call transcript
Q2 2023 Earnings call transcript
Q2 2022 Earnings call transcript
Q4 2021 Earnings call transcript
Q2 2021 Earnings call transcript
Q4 2020 Earnings call transcript
Q2 2020 Earnings call transcript
Q4 2019 Earnings call transcript

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	1.97	1.62	21.76
net income per share	0.29	-0.14	301.72
operating cash flow per share	0.3	0.22	34.13
free cash flow per share	0.21	0.18	18.68
cash per share	0.42	0.29	46.55
book value per share	-0.43	-0.72	39.76
tangible book value per share	-0.64	-1.21	46.80
shareholders equity per share	-0.44	-0.72	39.24
interest debt per share	0.73	0.75	-2.84
market cap	25057917000	7781267749.53	222.03
enterprise value	27311917000	11364267749.53	140.33
pe ratio	10.39	-6.52	259.41
price to sales ratio	1.52	0.58	164.09
pocfratio	10.08	4.21	139.74
pfcf ratio	14.14	5.22	170.96
pb ratio	-6.81	-1.29	-429.28
ptb ratio	-6.81	-1.29	-429.28
ev to sales	1.66	0.84	97.09
enterprise value over ebitda	7.29	8.8	-17.13
ev to operating cash flow	10.99	6.14	78.92
ev to free cash flow	15.41	7.62	102.22
earnings yield	0.1	-0.15	162.73
free cash flow yield	0.07	0.19	-63.09
debt to equity	-1.56	-0.98	-58.95
debt to assets	0.18	0.2	-9.62
net debt to ebitda	0.6	2.78	-78.31
current ratio	1.22	1.15	5.72
interest coverage	5.27	0.99	433.05
income quality	1.03	-1.46	170.67
dividend yield	0.0	0.0	-68.95
payout ratio	0.0	-0.0	149.50
sales general and administrative to revenue	0.07	0.08	-15.48
research and ddevelopement to revenue	0.04	0.06	-23.96
intangibles to total assets	0.06	0.14	-59.89
capex to operating cash flow	0.29	0.19	47.86
capex to revenue	0.04	0.03	62.88
capex to depreciation	0.75	0.47	60.90
stock based compensation to revenue	0.0	0.0	15.16
graham number	1.69	1.53	10.71
roic	0.11	0.02	554.79
return on tangible assets	0.08	-0.05	272.13
graham net net	-3.49	-3.33	-4.92
working capital	3239000000	2093000000	54.75
tangible asset value	-5388000000	-10114000000	46.73
net current asset value	-16921000000	-19455000000	13.02
invested capital	9631000000	11188000000	-13.92
average receivables	1950000000	3783000000	-48.45
average payables	1671500000	1503500000	11.17
average inventory	4778000000	4187000000	14.12
days sales outstanding	0	105.29	-100.00
days payables outstanding	45.62	58.84	-22.47
days of inventory on hand	137.53	159.66	-13.86
receivables turnover	0	3.47	-100.00
payables turnover	8.0	6.2	28.98
inventory turnover	2.65	2.29	16.09
roe	-0.66	0.2	-432.02
capex per share	0.09	0.04	98.32

• Negative

  ROE: Return on Equity (ROE) decreased to -0.66 on 2023-12-31 from 0.20 on 2022-12-31, representing a change of -432.02%. Suggesting that the company has not been generating high returns for its shareholders.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 10.39 on 2023-12-31 from -6.52 on 2022-12-31, representing a change of 259.41%. Indicating an increase in the relative valuation of the company's stock.

  Current Ratio: Current Ratio increased to 1.22 on 2023-12-31 from 1.15 on 2022-12-31, representing a change of 5.72%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to -1.56 on 2023-12-31 from -0.98 on 2022-12-31, representing a change of -58.95%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Quarterly Financial Ratios

	2024-06-30 Q2	2024-03-31 Q1	Q/Q change %
RR.L
calendar year	2024	2024	NaN
revenue per share	0.53	0.53	0.00
net income per share	0.07	0.07	0.00
operating cash flow per share	0.1	0.1	0.00
free cash flow per share	0.09	0.09	0.00
cash per share	0.51	0.51	0.00
book value per share	-0.27	-0.27	0.00
tangible book value per share	-0.47	-0.47	0.00
shareholders equity per share	-0.27	-0.27	0.00
interest debt per share	0.59	0.59	0.00
market cap	38170741011.63	35312993396.14	8.09
enterprise value	38839741011.63	35981993396.14	7.94
pe ratio	16.61	15.37	8.09
price to sales ratio	8.62	7.97	8.09
pocfratio	45.74	42.32	8.09
pfcf ratio	49.7	45.98	8.09
pb ratio	-16.65	-15.41	-8.09
ptb ratio	-16.65	-15.41	-8.09
ev to sales	8.77	8.12	7.94
enterprise value over ebitda	61.8	57.25	7.94
ev to operating cash flow	46.54	43.12	7.94
ev to free cash flow	50.57	46.85	7.94
earnings yield	0.02	0.02	-7.49
free cash flow yield	0.02	0.02	-7.49
debt to equity	-2.18	-2.18	0.00
debt to assets	0.15	0.15	0.00
net debt to ebitda	1.06	1.06	0.00
current ratio	1.28	1.28	0.00
interest coverage	0	0	NaN
income quality	1.45	1.45	0.00
dividend yield	0	0	NaN
payout ratio	0	0	NaN
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0.04	0.04	0.00
intangibles to total assets	0.05	0.05	0.00
capex to operating cash flow	0.08	0.08	0.00
capex to revenue	0.02	0.02	0.00
capex to depreciation	0.66	0.66	0.00
stock based compensation to revenue	0.01	0.01	0.00
graham number	0.65	0.65	0.00
roic	0.03	0.03	0.00
return on tangible assets	0.02	0.02	0.00
graham net net	-2.96	-2.96	0.00
working capital	4221000000	4221000000	0.00
tangible asset value	-3944000000	-3944000000	0.00
net current asset value	-15763000000	-15763000000	0.00
invested capital	10380000000	10380000000	0.00
average receivables	4319000000	4162500000	3.76
average payables	2166000000	1887000000	14.79
average inventory	5449000000	5148500000	5.84
days sales outstanding	87.74	87.74	0.00
days payables outstanding	57.73	57.73	0.00
days of inventory on hand	145.24	145.24	0.00
receivables turnover	1.03	1.03	0.00
payables turnover	1.56	1.56	0.00
inventory turnover	0.62	0.62	0.00
roe	-0.25	-0.25	0.00
capex per share	0.01	0.01	0.00

• Negative

  ROE: Return on Equity (ROE) decreased to -0.25 on 2024-06-30 Q2 from -0.25 on 2024-03-31 Q1, representing a change of 0.00%. Suggesting that the company has not been generating high returns for its shareholders.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 16.61 on 2024-06-30 Q2 from 15.37 on 2024-03-31 Q1, representing a change of 8.09%. Indicating an increase in the relative valuation of the company's stock.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to -2.18 on 2024-06-30 Q2 from -2.18 on 2024-03-31 Q1, representing a change of 0.00%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Neutral

  Current Ratio: Current Ratio decreased to 1.28 on 2024-06-30 Q2 from 1.28 on 2024-03-31 Q1, representing a change of 0.00%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Negative Sentiment: Discounted Cash Flow value is -46.81 which is lower than current price 611.6, indicates the company may be overvalued.